These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 29867968)
1. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines. Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S Front Immunol; 2018; 9():991. PubMed ID: 29867968 [TBL] [Abstract][Full Text] [Related]
2. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features. Šustić M; Cokarić Brdovčak M; Lisnić B; Materljan J; Juranić Lisnić V; Rožmanić C; Indenbirken D; Hiršl L; Busch DH; Brizić I; Krmpotić A; Jonjić S Front Immunol; 2021; 12():681380. PubMed ID: 34168650 [TBL] [Abstract][Full Text] [Related]
3. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. Slavuljica I; Busche A; Babić M; Mitrović M; Gašparović I; Cekinović D; Markova Car E; Pernjak Pugel E; Ciković A; Lisnić VJ; Britt WJ; Koszinowski U; Messerle M; Krmpotić A; Jonjić S J Clin Invest; 2010 Dec; 120(12):4532-45. PubMed ID: 21099111 [TBL] [Abstract][Full Text] [Related]
4. Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ. Trsan T; Busche A; Abram M; Wensveen FM; Lemmermann NA; Arapovic M; Babic M; Tomic A; Golemac M; Brinkmann MM; Jäger W; Oxenius A; Polic B; Krmpotic A; Messerle M; Jonjic S Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16550-5. PubMed ID: 24052528 [TBL] [Abstract][Full Text] [Related]
5. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263 [TBL] [Abstract][Full Text] [Related]
12. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. Hasan M; Krmpotic A; Ruzsics Z; Bubic I; Lenac T; Halenius A; Loewendorf A; Messerle M; Hengel H; Jonjic S; Koszinowski UH J Virol; 2005 Mar; 79(5):2920-30. PubMed ID: 15709011 [TBL] [Abstract][Full Text] [Related]
13. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication. Morello CS; Ye M; Spector DH J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299 [TBL] [Abstract][Full Text] [Related]
14. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. Lenac T; Budt M; Arapovic J; Hasan M; Zimmermann A; Simic H; Krmpotic A; Messerle M; Ruzsics Z; Koszinowski UH; Hengel H; Jonjic S J Exp Med; 2006 Aug; 203(8):1843-50. PubMed ID: 16831899 [TBL] [Abstract][Full Text] [Related]